These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1696042)

  • 1. The distribution of immuno-reactive tenascin in the epithelial-mesenchymal junctional areas of benign and malignant squamous epithelia.
    Anbazhagan R; Sakakura T; Gusterson BA
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(1):59-63. PubMed ID: 1696042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenascin expression in hyperproliferative skin diseases.
    Schalkwijk J; Van Vlijmen I; Oosterling B; Perret C; Koopman R; Van den Born J; Mackie EJ
    Br J Dermatol; 1991 Jan; 124(1):13-20. PubMed ID: 1704250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of the OVOL1-OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma.
    Ito T; Tsuji G; Ohno F; Nakahara T; Uchi H; Furue M
    Mod Pathol; 2017 Jul; 30(7):919-927. PubMed ID: 28339425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma.
    Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Chen SJ; Tomoeda H; Uenotsuchi T; Tu YT; Furue M; Urabe K
    J Dermatol Sci; 2008 Sep; 51(3):210-5. PubMed ID: 18547788
    [No Abstract]   [Full Text] [Related]  

  • 6. The basal lamina in basal cell carcinoma, Bowen's disease, squamous cell carcinoma and keratoacanthoma: an immunoperoxidase study using an antibody to type IV collagen.
    McArdle JP; Roff BT; Muller HK; Murphy WH
    Pathology; 1984 Jan; 16(1):67-72. PubMed ID: 6371685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
    Hughes JH; Robinson RA
    Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin expression in skin tumors using an AMeX immunohistostaining method.
    Koseki S; Ansai S; Aoki T; Hozumi Y; Mitsuhashi Y; Kondo S
    J Dermatol; 2000 May; 27(5):307-11. PubMed ID: 10875196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of the neutral cysteine protease bleomycin hydrolase in human skin.
    Takeda A; Nonaka M; Ishikawa A; Higuchi D
    Arch Dermatol Res; 1999 Apr; 291(4):238-40. PubMed ID: 10335922
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of promyelocytic leukaemia protein in Bowen's disease, skin squamous cell carcinoma and basal cell carcinoma].
    Wang Q; Ma H; Wang S; Ma Y; Zou X; Li R
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1075-7. PubMed ID: 23895857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-8 immunoreactivity in malignant tumours of the skin.
    Bornscheuer E; Schröder JM; Christophers E; Sticherling M
    Acta Derm Venereol; 1996 May; 76(3):210-3. PubMed ID: 8800301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma].
    Li ZX; Peng ZH; Ji FP; Yuan JY; Pan M; Liu Y; Wang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1245-7. PubMed ID: 16939929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of L-type amino acid transporter 1 in various skin lesions.
    Hirano K; Uno K; Kuwabara H; Kojima K; Ohno S; Sakurai H; Kamma H; Kurata A
    Pathol Res Pract; 2014 Oct; 210(10):634-9. PubMed ID: 24939142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cell proliferation in benign, premalignant and malignant skin lesions.
    Bordbar A; Dias D; Cabral A; Beck S; Boon ME
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):229-35. PubMed ID: 17525640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenascin distribution in basal cell carcinomas.
    Stamp GW
    J Pathol; 1989 Nov; 159(3):225-9. PubMed ID: 2480437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P27 and mib1 expression in actinic keratosis, Bowen disease, and squamous cell carcinoma.
    Oh CW; Penneys N
    Am J Dermatopathol; 2004 Feb; 26(1):22-6. PubMed ID: 14726819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
    Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
    Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced tenascin immunoreactivity in leukoplakia and squamous cell carcinoma of the oral cavity: an immunohistochemical study.
    Shrestha P; Sakamoto F; Takagi H; Yamada T; Mori M
    Eur J Cancer B Oral Oncol; 1994; 30B(2):132-7. PubMed ID: 7518275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratin expression in normal skin and epidermal neoplasms demonstrated by a panel of monoclonal antibodies.
    Perkins W; Campbell I; Leigh IM; MacKie RM
    J Cutan Pathol; 1992 Dec; 19(6):476-82. PubMed ID: 1283171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.